Consolidation Immunotherapy in Unresectable Early NSCLC: PAC

Ben Levy, MD, reviews the 5-year update and clinical implications of the PACIFIC study which evaluated consolidation immunotherapy in unresectable early-stage NSCLC.

Related Keywords

, Recent Updates , Translating Evidence , Clinical Practice , Unresectable Early , Nsclc , Early Nsclc , Non Small Cell Lung Cancer , Asco 2023 , Localized Disease , Presection , Surgery , Staging , Chemoimmunotherapy , Immunotherapy , Ohio , Molecular Testing , Liquid Biopsy , Tissue Biopsy , Ngs Testing , Egfr , Talk ,